Hospital care costs are out of control. Price caps can help.
By Andy Ryan and Roslyn Murray of Brown University
New research on "biomarkers" is enabling us to recognize signs of developmental disorders much earlier in life.
Disciplines:
Medicine & PsychologyBarry M. Lester, Ph.D. is Professor of Psychiatry & Human Behavior and Pediatrics and Director of the Brown Center for the Study of Children at Risk at the Brown Alpert Medical School and Women & Infants Hospital. The Brown Center also includes the Center for Children and Families at Women & Infants Hospital. The Centers provide research and clinical services for infants at risk and their families as well as research and clinical training. Dr. Lester's research has been federally funded throughout his career. He has been heavily involved in the NIH peer review process serving on NIH study sections, the NIH National Advisory Council on Drug Abuse, the NIH Director's Pioneer Award Program and the College of the Center for Scientific Review. He is past president of the International Association for Infant Mental Health and the author of more than 250 peer reviewed publications and 100 chapters and books.
Disciplines:
Medicine & PsychiatryStephen J. Sheinkopf is an associate professor of psychiatry and pediatrics at The Warren Alpert Medical School of Brown University. Dr. Sheinkopf works as both a clinician and a researcher with expertise is the area of autism and developmental disabilities. Dr. Sheinkopf’s clinical service is focused on the early diagnosis and clinical management of autism. His primary research interests include the identification of very early signs of autism in infancy, the development of social communication abilities in young children with autism, and neurodevelopmental outcomes in children exposed to drugs prenatally. Dr. Sheinkopf is co-director of the Rhode Island Consortium for Autism Research and Treatment and co-leader of the autism research initiative in the Hassenfeld Child Health Innovation Institute at the Brown School of Public Health. He completed his Ph.D. at the University of Miami.
By Stephen Sheinkopf & Barry Lester, Brown University
Many new parents watch eagerly to see if their child is hitting developmental milestones, poring over parenting books and consulting doctors at the smallest hint of difficulty. Yet even if they start to notice signs that their child may be among the one in six who have a developmental disability, parents generally have to wait and watch to know for sure. In the case of autism, caregivers often notice differences in their child’s first one to two years, even as the average age of formal diagnosis remains at 4 to 5 years old.
What if we could recognize signs of developmental disorders much earlier, saving parents years of confusion and worry and helping address challenges sooner? At Brown University’s Hassenfeld Child Health Innovation Institute, we’re studying “biomarkers” that have the potential to identify a child’s risk for autism and other developmental disorders well before more obvious symptoms are apparent. Initial research, for example, suggests that characteristics in the cry of a one-month old infant have the potential to predict whether they will later be diagnosed with autism…
Read the full article online at The Boston Globe.
This article was produced by Footnote in partnership with the Hassenfeld Child Health Innovation Institute at the Brown University School of Public Health.
Get in touch about this workA secure, centralized workspace where faculty upload notes, papers, and lecture materials—and instantly receive clear, accurate, publication-ready drafts across formats: op-eds, research briefs, executive summaries, pitches, public commentary, and more.
Discover More